Image Guided Radiotherapy - Global Strategic Business Report

The global market for Image Guided Radiotherapy was estimated at US$1.9 Billion in 2024 and is projected to reach US$2.3 Billion by 2030, growing at a CAGR of 3.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Image Guided Radiotherapy market.

Global Image Guided Radiotherapy Market - Key Trends and Drivers Summarized

How Is Image Guided Radiotherapy Revolutionizing Cancer Treatment?

Image Guided Radiotherapy (IGRT) is transforming the field of oncology by enhancing the precision and effectiveness of cancer treatments. IGRT combines advanced imaging techniques with radiation therapy to target tumors more accurately while sparing surrounding healthy tissues. By utilizing real-time imaging technologies such as CT scans, MRIs, and X-rays, IGRT allows clinicians to monitor the tumor’s position and adjust radiation beams accordingly during treatment sessions. This level of precision is particularly crucial in treating tumors that move due to breathing or other bodily functions, as it ensures that the radiation dose is delivered precisely where it is needed, minimizing side effects and improving patient outcomes. The ability of IGRT to adapt to changes in tumor size, shape, and location over the course of treatment makes it a powerful tool in the fight against cancer, offering hope for better control of the disease with fewer complications.

What Technological Innovations Are Enhancing IGRT’s Capabilities?

The capabilities of Image Guided Radiotherapy have been significantly enhanced by recent technological advancements that improve its accuracy, efficiency, and overall effectiveness. One of the most notable innovations is the integration of advanced imaging modalities, such as 4D imaging, which provides dynamic visualizations of the tumor in real-time, accounting for its movement and changes during treatment. Additionally, the development of linear accelerators with built-in imaging systems has streamlined the treatment process, allowing for continuous monitoring and adjustment of radiation doses without the need to reposition the patient. The use of artificial intelligence (AI) and machine learning algorithms is further enhancing IGRT by enabling automated analysis of imaging data, which helps in identifying subtle changes in tumor positioning and optimizing treatment plans accordingly. These technological advancements are not only making IGRT more precise but are also reducing treatment times and improving patient comfort, setting new standards in radiotherapy.

How Are Healthcare Needs and Market Demands Shaping the Adoption of IGRT?

The adoption of Image Guided Radiotherapy is being driven by the increasing demand for personalized cancer treatments and the growing prevalence of cancer worldwide. As more patients seek treatments that offer fewer side effects and better outcomes, IGRT is becoming a preferred option due to its ability to deliver highly targeted therapy. The rising incidence of cancers that are difficult to treat with conventional radiotherapy, such as those located near critical organs or in regions prone to movement, is also fueling the demand for IGRT. Healthcare providers are increasingly adopting IGRT to improve the quality of care, reduce treatment-related complications, and enhance patient satisfaction. Furthermore, the shift towards value-based healthcare is encouraging the use of technologies that provide better outcomes and cost-effectiveness, making IGRT an attractive investment for hospitals and cancer treatment centers. These market demands are shaping the future of radiotherapy, with IGRT playing a central role in the evolution of cancer care.

What Factors Are Driving Growth in the Image Guided Radiotherapy Market?

The growth in the Image Guided Radiotherapy (IGRT) market is driven by several factors, including advancements in imaging technology, the increasing incidence of cancer, and the growing emphasis on precision medicine. Technological advancements, such as the development of 4D imaging and AI-driven treatment planning, are significantly enhancing the capabilities of IGRT, making it a more effective and accessible option for cancer treatment. The rising incidence of cancer globally is another major driver, as it increases the demand for advanced radiotherapy solutions that can offer better outcomes with fewer side effects. Additionally, the trend towards precision medicine, which focuses on tailoring treatments to the individual characteristics of each patient, is boosting the adoption of IGRT, as it allows for highly personalized and targeted therapy. The ongoing push for improved healthcare outcomes and the reduction of treatment-related complications are also contributing to the growth of the IGRT market, as healthcare providers seek to offer the best possible care to their patients. As these factors continue to influence the healthcare landscape, the demand for IGRT is expected to grow, solidifying its role as a key technology in cancer treatment.

SCOPE OF STUDY:

The report analyzes the Image Guided Radiotherapy market in terms of units by the following Segments, and Geographic Regions/Countries:

• Segments: Device Type (Linear Accelerators, CT Scanning Devices, Portal Imaging Devices, 4D Radiotherapy Devices, PET / MRI-Guided Radiation Therapy Devices); End-Use (Hospitals End-Use, Radiotherapy Centers End-Use, Other End-Uses)
• Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Linear Accelerators segment, which is expected to reach US$885.0 Million by 2030 with a CAGR of a 4.0%. The CT Scanning Devices segment is also set to grow at 3.0% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $516.8 Million in 2024, and China, forecasted to grow at an impressive 6.7% CAGR to reach $488.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Image Guided Radiotherapy Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Image Guided Radiotherapy Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Image Guided Radiotherapy Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Accuray, Inc., Canon Medical Systems Corporation, Canon Medical Systems Corporation, C-RAD AB, Elekta AB and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 43 companies featured in this Image Guided Radiotherapy market report include:

• Accuray, Inc.
• Canon Medical Systems Corporation
• Canon Medical Systems Corporation
• C-RAD AB
• Elekta AB
• GE Healthcare
• Hitachi High-Tech Corporation-Healthcare Business Group
• IBA Worldwide
• Mevion Medical Systems, Inc.
• Panacea Medical Technologies Pvt. Ltd.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.